Table 2.

Associations between Liver Fibrosis Indices and Admission Hematoma Volume, Hematoma Expansion, and Outcomes after ICH

Outcome	APRI*		FIB-4*		NFS*
	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Hematoma expansion	1.6 (1.1–2.3)	0.01	1.9 (1.2–3.0)	0.01	1.2 (0.9–1.5)	0.22
All-cause mortality	1.8 (1.1–2.7)	0.01	2.0 (1.1–3.6)	0.02	1.2 (0.9–1.8)	0.22
Death or major disability	1.3 (0.9–1.8)	0.19	1.3 (0.8–2.1)	0.31	0.9 (0.8–1.2)	0.71
	Beta (SE)	p value	Beta (SE)	p value	Beta (SE)	p value
Admission hematoma volume*,†	0.20 (0.08)	0.01	0.27 (0.11)	0.01	0.03 (0.05)	0.53

Abbreviations: mRS, modified Rankin Scale; APRI, aspartate aminotransferase-platelet ratio index; FIB-4, fibrosis-4 score; NFS, Nonalcoholic Fatty Liver Disease Fibrosis score, SE, Standard Error.

^*Logarithmic transformation was performed to minimize skewness.

^†Linear regression was used.